InNexus Biotechnology, Inc.
IXSBF · OTC
6/30/2010 | 6/30/2009 | 6/30/2008 | 6/30/2007 | |
|---|---|---|---|---|
| Market Cap | $2,562 | $10,059 | $13,547 | $15,532 |
| - Cash | $0 | $124 | $3,122 | $2,861 |
| + Debt | $3,364 | $2,574 | $0 | $0 |
| Enterprise Value | $5,925 | $12,509 | $10,426 | $12,671 |
| Revenue | $0 | $0 | $1 | $15 |
| % Growth | – | -100% | -93.4% | – |
| Gross Profit | $0 | $0 | -$610 | -$242 |
| % Margin | – | – | -60,403.4% | -1,583.8% |
| EBITDA | -$2,942 | -$6,293 | -$5,210 | -$5,497 |
| % Margin | – | – | -515,888.8% | -35,991.8% |
| Net Income | -$6,689 | -$8,017 | -$5,888 | -$5,172 |
| % Margin | – | – | -582,934.9% | -33,861.5% |
| EPS Diluted | -0.07 | -0.11 | -0.11 | -0.13 |
| % Growth | 36.4% | 0% | 15.4% | – |
| Operating Cash Flow | -$1,591 | -$3,317 | -$8,445 | -$2,063 |
| Capital Expenditures | -$12 | -$87 | -$1,174 | -$834 |
| Free Cash Flow | -$1,603 | -$3,403 | -$9,619 | -$2,898 |